← Open Payments lookup

KATHLEEN LEVY: Open Payments

NPI 1679917918 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,604 in 22 payments from 11 companies in 2025. Trend: 2023 $1,992 · 2024 $9,804 · 2025 $2,604

Honoraria: $2,200Food & beverage: $404
CompanyPaymentsAmount
Axsome Therapeutics, Inc.1$2,200
Bausch Health US, LLC4$65
Neurocrine BioSciences, Inc.3$63
ABBVIE INC.3$54
Otsuka America Pharmaceutical, Inc.3$54
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Teva Pharmaceuticals USA, Inc.2$36
Vanda Pharmaceuticals Inc.1$26
Alkermes, Inc.1$22
Takeda Pharmaceuticals U.S.A., Inc.1$18

Products named: Auvelity, APLENZIN, INGREZZA, VRAYLAR, REXULTI, CAPLYTA, AUSTEDO XR, FANAPT.

Industry payments across NY — which companies pay providers there.